Imdelltra

Asia

Pharma

Merck-Curon, Legend, Amgen—Fierce Pharma Asia

Merck licensed a bispecific from Curon. Legend is taking a close look at its business. The FDA flagged missing adverse events in an Amgen filing.

Angus Liu Aug 16, 2024 8:59am

FDA Building

FDA noted 'large number' of missing AEs in Amgen's Imdelltra app

Aug 14, 2024 6:45am

Amgen

FDA approves Amgen's potential lung cancer blockbuster Imdelltra

May 17, 2024 12:12pm